Joshua Reed | Chief Financial Officer |
Todd Brady | President & Chief Executive Officer |
David McMullin | Chief Business Officer |
Samantha Semenkow | Citi |
Jennifer Kim | Cantor Fitzgerald |
Jackie Yan | Oppenheimer |
Matt Cross | Alliance Global Partners |
Julian Harrison | BTIG |
Kelly Shi | Jefferies |
Good morning and welcome to the Aldeyra Therapeutics Third Quarter 2020 Financial Results Conference call. After the speaker's presentation, there will be a question and answer session.
If you would like to ask a question during that time, please press star, then the number one on your telephone keypad. At this time, I would like to turn the call over to Mr. Joshua Reed, the Company's Chief Financial Officer.